Events during March 2022

13.30 Influenza-like-Illness testing and its importance as SARS-CoV-2 moves from pandemic to endemic Gavin Wall MSc MBA DipRCPath, Director of Medical Affairs (Infectious Diseases), QIAGEN

13.00 Introducing the PATHFAST™
- Emergency Marker High Sensitivity Troponin I assay into the Emergency Department
Ian Smith, AB Scientific

14.30 Data Driven Pathology Martin Wilkinson, Director of Product Introduction, Strategy and User Adoption, InterSystems

14.00 The next revolution in infectious disease testing -
integrating prognosis and diagnosis by reading the host response
Dr. Florian Uhle. Inflammatix, Associate Director Medical Affairs Europe, Pro-Lab Diagnostics

15.00 Bringing Fungal Diagnostics In-House Andrew Wood, General Manager, BioConnections

16.30 East Kent Hospital inactivate SARS-CoV-2 in 60secs, revolutionising their workflow processes.
Michael Dawson, Medical Wire Equipment

16.00 Quality improvement in the pre-analytical phase
Fabio Sgarabottolo, A. Menarini Diagnostics

10.30 New ISO risk and safety standards
David Ricketts, Head of Laboratory Process Improvement, Health Services Laboratories LLP

11.30 Rethinking transfusion safety Nicola Swarbrick, Laboratory Incident Specialist, Serious Hazards of Transfusion (SHOT)

11.00 Covid-19: the safety considerations associated with diagnostic testing and the vaccine response
Vin Poran, Health and Safety Executive